HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dual-acting antitumor Pt(iv) prodrugs of kiteplatin with dichloroacetate axial ligands.

Abstract
With the aim to obtain dual acting drugs able to target both nuclear DNA and mitochondria, Pt(iv) kiteplatin derivatives having dichloroacetate (DCA) ligands in axial positions have been synthesized. The rather fast hydrolysis (t1/2 of ca. 1 h) and reduction (by ascorbic acid) of these Pt(iv) derivatives did not impede a potent pharmacological effect on tumor cells. Moreover, similarly to kiteplatin, also the Pt(iv)-DCA compounds proved to be capable of overcoming oxaliplatin-resistance, which is particularly important in view of the fact that metastatic colorectal cancer is the third most common cancer in males and the second in females. The possible role of DCA released by the Pt(iv) compounds in eliciting the antiproliferative activity has also been investigated. Pt(iv)-DCA compounds determine a substantial increase of ROS production, blockage of oxidative phosphorylation, hypopolarization of the mitochondrial membrane, and caspase-3/7 mediated apoptotic cell death.
AuthorsSalvatore Savino , Valentina Gandin , James D Hoeschele , Cristina Marzano , Giovanni Natile , Nicola Margiotta
JournalDalton transactions (Cambridge, England : 2003) (Dalton Trans) Vol. 47 Issue 21 Pg. 7144-7158 (May 29 2018) ISSN: 1477-9234 [Electronic] England
PMID29766157 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • Ligands
  • Organoplatinum Compounds
  • Prodrugs
  • Reactive Oxygen Species
  • platinum(II)(1,4-diazacycloheptane)dichloride
  • Dichloroacetic Acid
Topics
  • Antineoplastic Agents (chemical synthesis, chemistry, pharmacology)
  • Cell Death (drug effects)
  • Cell Line, Tumor
  • Cell Proliferation (drug effects)
  • Dichloroacetic Acid (chemistry, pharmacology)
  • Drug Screening Assays, Antitumor
  • Humans
  • Ligands
  • Molecular Structure
  • Organoplatinum Compounds (chemical synthesis, chemistry, pharmacology)
  • Prodrugs (chemical synthesis, chemistry, pharmacology)
  • Reactive Oxygen Species (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: